We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ED:NYSEConsolidated Edison, Inc. Analysis

Data as of 2026-06-17 - not real-time

$108.37

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Consolidated Edison (ED) is trading at $108.37, just above its 20‑day (≈$106.4) and 200‑day (≈$104.3) simple moving averages and marginally above the 50‑day SMA (≈$108.2), indicating a modest short‑term bullish bias. The RSI sits at 55, the MACD histogram is positive and the MACD signal is deemed bullish, while the price is testing a resistance near $109.4 and a support around $102.8, suggesting limited upside momentum. Volatility over the past 30 days is high for a utility at ~18.7% and volume is decreasing, which adds a layer of price uncertainty despite a low beta that points to modest market‑wide risk.
Fundamentally, ED’s trailing PE of ~18.3 is below the industry average of ~20.7, and it offers a solid dividend yield of 3.21% with a payout ratio of 58%, supporting dividend sustainability. However, the company carries a very high debt‑to‑equity ratio (>100) and free cash flow is negative, raising concerns about leverage and cash generation. Recent analyst sentiment has turned cautious, with Morgan Stanley cutting its target to $99 and Mizuho downgrading to Neutral, reflecting limited upside (≈1.3% upside vs downside) despite a fair valuation relative to peers.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with limited upside
  • Recent analyst downgrades and lower price targets
  • Strong dividend yield providing near‑term income

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable regulated cash flows offsetting high leverage
  • Valuation roughly in line with sector peers
  • Continued dividend payments supporting total return

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term regulated revenue base
  • Dividend sustainability despite debt load
  • Potential for modest earnings growth balanced by capital‑intensive investments

Key Metrics & Analysis

Financial Health

Revenue Growth6.20%
Profit Margin12.52%
P/E Ratio18.3
ROE8.73%
ROA3.17%
Debt/Equity106.18
P/B Ratio1.6
Op. Cash Flow$4.1B
Free Cash Flow$-833249984
Industry P/E20.7

Technical Analysis

TrendNeutral
RSI55.3
Support$102.82
Resistance$109.42
MA 20$106.41
MA 50$108.21
MA 200$104.31
MACDBullish
VolumeDecreasing
Fear & Greed Index92.16

Valuation

Fair Value$61.86
Target Price$109.75
Upside/Downside1.27%
GradeFair
TypeValue
Dividend Yield3.21%

Risk Assessment

Beta-0.40
Volatility18.71%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.